Dr. Shou-Ching Tang will serve as the Associate Dean for Translational Research
We are pleased to announce that Shou-Ching Tang, MD, PhD, FACP, FRCPC has agreed to serve as Associate Dean for Translational Research. He will also serve as the Associate Director for Clinical Research at the LSU-LCMC Cancer Center and Director of Phase I Clinical Trials Program. Dr. Tang earned his MD degree with honors from West China University of Medical Sciences and a PhD degree in molecular biology from the University of Alberta in Edmonton, Alberta, Canada. He completed his medical oncology fellowship at the Princess Margaret Hospital (Toronto, Canada) and is certified in Medical Oncology by the American Board of Internal Medicine and the Royal College of Physicians and Surgeons of Canada. Dr. Tang comes to LSU from the University of Mississippi School of Medicine where he served as the Associate Director for Clinical and Translational Research at the Cancer and Research Institute, Director of Phase I Clinical Trials and Interdisciplinary Experimental Therapeutic Program and Chair of Clinical Leadership Council for the Cancer Service Line at the University of Mississippi Medical Center.
Dr. Tang founded the Asia International Breast Cancer Summit, the Atlantic Canada Oncology Group (ACOG) and the US Chinese Anticancer Association (USCACA). He has held many leadership and administrative positions at academic institutions and NCI-Designated Cancer Centers and is a renowned clinician scientist. His translational research is focused on oncogenesis, drug resistance, molecular immunology and prognostic and predictive biomarkers. Notably, his laboratory discovered the anti-apoptotic protein BAG-1 as a prognostic factor in solid tumors and developed novel BAG-1-targeted therapy. He has published 145 peer-reviewed papers and serves on the editorial board of six peer-reviewed international journals.
Please join us in welcoming Dr. Tang to the LSU School of Medicine and to his new role as Associate Dean for Translational Research.